Overview
Alex Soltermann practices practicing medicine in Zurich, Switzerland.
Mr. Soltermann is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Squamous Cell Lung Carcinoma, Lung Cancer, and Lung Adenocarcinoma.
He is actively involved in clinical research, co-authoring 94 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alex Soltermann
Is Alex Soltermann a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Alex Soltermann is classified as an Distinguished expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alex Soltermann participate in research or clinical trials?
Yes. Alex Soltermann has published 94 articles and abstracts on conditions like Mesothelioma. You can view a list of Alex Soltermann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaMr. Soltermann isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Soltermann isDistinguished. Learn about Lung Cancer.
- MesotheliomaMr. Soltermann isDistinguished. Learn about Mesothelioma.
- Squamous Cell Lung CarcinomaMr. Soltermann isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Non-Small Cell Lung Cancer (NSCLC)Mr. Soltermann isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleural EffusionMr. Soltermann isAdvanced. Learn about Pleural Effusion.
- Experienced
- Adult Soft Tissue SarcomaMr. Soltermann isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-TelangiectasiaMr. Soltermann isExperienced. Learn about Ataxia-Telangiectasia.
- Cerebral HypoxiaMr. Soltermann isExperienced. Learn about Cerebral Hypoxia.
- Erythema NodosumMr. Soltermann isExperienced. Learn about Erythema Nodosum.
- Human Papillomavirus InfectionMr. Soltermann isExperienced. Learn about Human Papillomavirus Infection.
- Neuroendocrine TumorMr. Soltermann isExperienced. Learn about Neuroendocrine Tumor.
- PIK3CA-Related Overgrowth SpectrumMr. Soltermann isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Pyoderma GangrenosumMr. Soltermann isExperienced. Learn about Pyoderma Gangrenosum.
- Pyogenic GranulomaMr. Soltermann isExperienced. Learn about Pyogenic Granuloma.
- Small Cell Lung Cancer (SCLC)Mr. Soltermann isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Solitary Fibrous TumorMr. Soltermann isExperienced. Learn about Solitary Fibrous Tumor.